NSNiloofar Shashaani

Niloofar Shashaani

*This is an algorithmically generated author record based on publicly available information.

Niloofar Shashaani has a total of 2 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Juvenile Idiopathic Arthritis

    by Vadood Javadi, Niloofar Shashaani, Khosro Rahmani

    Juvenile idiopathic arthritis (JIA), previously known as juvenile rheumatoid arthritis, is the most common form of rheumatic disease in children under the age of 16. It is characterized by chronic joint inflammation of unknown origin. JIA is classified into several types based on the number of joints affected and other clinical characteristics, with the International League of Associations for Rheumatology criteria being the most widely recognized classification system. The primary types include oligoarticular JIA, which affects four or fewer joints; polyarticular JIA, impacting five or more joints; psoriatic arthritis; enthesitis-related arthritis; systemic-onset JIA; and undifferentiated arthritis. JIA typically presents with joint pain, swelling, and stiffness. It may also include systemic symptoms such as fever and fatigue, particularly in cases of systemic-onset JIA (2). Common complications can include growth abnormalities, joint contractures, and osteoporosis. Imaging techniques such as X-rays, magnetic resonance imaging, and ultrasounds are crucial for assessing joint involvement and monitoring disease progression. Managing JIA requires a multidisciplinary approach. This includes pharmacological treatments such as nonsteroidal anti-inflammatory drugs, corticosteroids, disease-modifying antirheumatic drugs, and physical therapy to enhance mobility and quality of life (3). Early diagnosis and treatment are essential for improving long-term outcomes, particularly for polyarticular and rheumatoid factor-positive subtypes, which tend to have a worse prognosis (4).